JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266736

Human SSR4 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SSR4 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 1 and 8 bp deletion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human SSR4 knockout HEK-293T cell line (AB266736)
  • Sanger seq

Unknown

Sanger Sequencing - Human SSR4 knockout HEK-293T cell line (AB266736)

Allele-1 : 10 bp deletion in exon 1

Sanger Sequencing - Human SSR4 knockout HEK-293T cell line (AB266736)
  • Sanger seq

Unknown

Sanger Sequencing - Human SSR4 knockout HEK-293T cell line (AB266736)

Allele-2 : 8 bp deletion in exon 1.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 1 and 8 bp deletion in exon 1

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266736-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266736-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266736 Human SSR4 knockout HEK-293T cell line", "number":"AB266736-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266736-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266736 Human SSR4 knockout HEK-293T cell line", "number":"AB266736-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266736-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266736-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266736 Human SSR4 knockout HEK-293T cell line", "number":"AB266736-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266736-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266736 Human SSR4 knockout HEK-293T cell line", "number":"AB266736-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SSR4
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SSR4 also known as TRG4 or CDG1S is a subunit of the signal recognition particle receptor responsible for the translocation of proteins across the membrane of the endoplasmic reticulum. With an approximate mass of 24 kDa SSR4 is expressed predominately in tissues with high secretory functions such as the liver and pancreas. It plays an important role in facilitating the proper insertion and folding of nascent polypeptide chains by cooperating with other components of the translocation machinery.
Biological function summary

SSR4 functions as part of the signal sequence receptor (SSR) complex. This complex is essential for the targeting and translocation of newly synthesized proteins into the endoplasmic reticulum lumen. SSR4 interacts directly with signal sequences of nascent polypeptides to ensure their correct orientation and localization during protein synthesis. Proper functioning of SSR4 is necessary for the homeostasis of the cellular secretory pathway.

Pathways

SSR4 is involved in the protein translocation pathway which is essential for protein sorting and trafficking. This pathway intersects with the unfolded protein response (UPR) pathway which maintains protein homeostasis under stress conditions. In these pathways SSR4 collaborates with proteins like Sec61 to mediate translocation and assist in protein folding. Disruptions in these pathways can lead to cellular dysfunction and stress-related responses.

Defects or alterations in SSR4 are linked to congenital disorders of glycosylation (CDGs) which affect multiple organ systems. Altered glycoprotein production in these disorders results from impaired protein translocation demonstrating SSR4's influence on glycoprotein processing. Furthermore SSR4 may interact with proteins like glycosyltransferases affecting their function in cellular processes and contributing to the broad clinical spectrum observed in CDGs.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com